title: Identification of promoter regions involved in cell- and developmental stage-specific osteopontin expression in bone, kidney, placenta, and mammary gland: an analysis of transgenic mice.
abstract: Cell-specific expression of GFP under the control of different lengths of the osteopontin promoter in transgenic mice identified the positive and negative regulatory regions for respective cell types. The results provide new insights for physiological and pathological expression of the osteopontin gene.
  
  
  BACKGROUND
  Osteopontin (OPN) is a major non-collagenous bone matrix protein that is involved in normal and pathological calcification and is expressed in a tissue-specific manner. To investigate how such tissue-specific OPN gene expression is regulated in vivo, transgenic mice expressing the green fluorescent protein (GFP) reporter gene controlled by different lengths of the OPN promoter were generated.
  
  
  METHODS
  Cell- and developmental stage-specific osteopontin expression in transgenic mice was examined by Northern blotting, immunoblotting, fluorescence examination, and in situ hybridization and compared with those of OPN.
  
  
  CONCLUSIONS
  The line bearing the -5505 to +14 region of the OPN promoter was shown by Northern blotting and immunoblotting to express GFP in the same cells that express endogenous OPN (osteoblasts, hypertrophic chondrocytes, renal and mammary gland epithelial cells, and granulated metrial gland [GMG] placental cells) at the same stage in development. Thus, the 5.5-kb -5505 to +14 promoter region is sufficient for proper tissue-specific OPN expression. The lines carrying shorter segments of the OPN promoter showed different expression patterns. These patterns revealed a putative cis-acting element in the -5269 to -5263 region that restricts OPN expression to hypertrophic chondrocytes and a mammary gland-specific expressing element and a GMG cell-specific enhancing element in the -5505 to -3156 region. Furthermore, the -3155 to -1576 region seems to contain positive renal epithelial cell- and GMG cell-specific expression motif(s) as well as a negative regulatory element that prevents OPN expression in fibroblasts. Moreover, the -1576 to -910 region seems to contain a positive osteoblast-specific-expressing element. Thus, the 5.5-kb OPN promoter contains multiple cis-acting elements encoding positive and negative cell-specific regulatory systems.
authors.affiliation: Department of Pathology, Graduate School of Osaka University Medical School, Suita, Osaka, Japan.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Higashibata
authors.forename: Takahiko
authors.initials: T
authors.lastname: Sakuma
authors.forename: Hirohisa
authors.initials: H
authors.lastname: Kawahata
authors.forename: Shinji
authors.initials: S
authors.lastname: Fujihara
authors.forename: Keiji
authors.initials: K
authors.lastname: Moriyama
authors.forename: Atsushi
authors.initials: A
authors.lastname: Okada
authors.forename: Takahiro
authors.initials: T
authors.lastname: Yasui
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Kohri
authors.forename: Yukihiko
authors.initials: Y
authors.lastname: Kitamura
authors.forename: Shintaro
authors.initials: S
authors.lastname: Nomura
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D015139:Blotting, Southern; D015153:Blotting, Western; D001842:Bone and Bones / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D002356:Cartilage / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D003433:Crosses, Genetic; D005260:Female; D018628:Gene Dosage; D015870:Gene Expression; D018507:Gene Expression Regulation, Developmental; D049452:Green Fluorescent Proteins; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007668:Kidney / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D007867:Leg Bones / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D008164:Luminescent Proteins / Q000032:analysis / Q000235:genetics; D008321:Mammary Glands, Animal / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D008957:Models, Genetic; D053495:Osteopontin; D010920:Placenta / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D011247:Pregnancy; D011401:Promoter Regions, Genetic / Q000235:genetics*; D011993:Recombinant Fusion Proteins / Q000032:analysis / Q000235:genetics; D012045:Regulatory Sequences, Nucleic Acid / Q000235:genetics; D012795:Sialoglycoproteins / Q000235:genetics*; D012867:Skin / Q000737:chemistry / Q000378:metabolism; D013131:Spine / Q000737:chemistry / Q000378:metabolism
chemical_list: D008164:Luminescent Proteins; D011993:Recombinant Fusion Proteins; D012795:Sialoglycoproteins; C506896:Spp1 protein, mouse; D053495:Osteopontin; D049452:Green Fluorescent Proteins